Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multiple-dose, randomized, two-period crossover bioequivalence study
in approximately 110 surgically or naturally postmenopausal women on stable hormone therapy
(i.e., estrogen for surgically postmenopausal women or a continuous regimen of estrogen plus
progestin for naturally postmenopausal women) restricted to approved oral or transdermal
regimens only, or not on concomitant hormone therapy.